These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36509943)

  • 1. The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2.
    Li W; Ma ZS
    Microb Ecol; 2023 Aug; 86(2):1428-1437. PubMed ID: 36509943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome.
    Shilts MH; Rosas-Salazar C; Strickland BA; Kimura KS; Asad M; Sehanobish E; Freeman MH; Wessinger BC; Gupta V; Brown HM; Boone HH; Patel V; Barbi M; Bottalico D; O'Neill M; Akbar N; Rajagopala SV; Mallal S; Phillips E; Turner JH; Jerschow E; Das SR
    Front Cell Infect Microbiol; 2021; 11():781968. PubMed ID: 35141167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General dynamics of the URT microbiome and microbial signs of recovery in COVID-19 patients.
    Ignatyeva O; Gostev V; Taraskina A; Tsvetkova I; Pavlova P; Sulian O; Ageevets V; Likholetova D; Chulkova P; Nikitina E; Matkava L; Terekhov M; Lisovaya D; Kashtanova D; Ivanov M; Kalinogorskaya O; Avdeeva A; Zhirkov A; Goleva O; Zakharenko S; Zhdanov K; Strizheletsky V; Gomon Y; Kruglov A; Ni O; Noskova T; Gorbova I; Cherenkova G; Shlyk I; Afanasyev A; Yudin V; Makarov V; Sidorenko S; Yudin S
    Benef Microbes; 2024 Feb; 15(2):145-164. PubMed ID: 38412868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
    Xie L; Luo G; Yang Z; Wu WC; Chen J; Ren Y; Zeng Z; Ye G; Pan Y; Zhao WJ; Chen YQ; Hou W; Sun Y; Guo D; Yang Z; Li J; Holmes EC; Li Y; Chen L; Shi M
    J Infect; 2024 Mar; 88(3):106118. PubMed ID: 38342382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper respiratory tract microbiome profiles in SARS-CoV-2 Delta and Omicron infected patients exhibit variant specific patterns and robust prediction of disease groups.
    Nath S; Sarkar M; Maddheshiya A; De D; Paul S; Dey S; Pal K; Roy SK; Ghosh A; Sengupta S; Paine SK; Biswas NK; Basu A; Mukherjee S
    Microbiol Spectr; 2023 Dec; 11(6):e0236823. PubMed ID: 37905804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Upper Respiratory Bacterial Microbiome in Critically Ill COVID-19 Patients.
    Bai X; Narayanan A; Skagerberg M; Ceña-Diez R; Giske CG; Strålin K; Sönnerborg A
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
    Moradi Marjaneh M; Challenger JD; Salas A; Gómez-Carballa A; Sivananthan A; Rivero-Calle I; Barbeito-Castiñeiras G; Foo CY; Wu Y; Liew F; Jackson HR; Habgood-Coote D; D'Souza G; Nichols SJ; Wright VJ; Levin M; Kaforou M; Thwaites RS; Okell LC; Martinón-Torres F; Cunnington AJ; ;
    J Infect; 2023 Dec; 87(6):538-550. PubMed ID: 37863321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
    Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
    Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Burrel S; Hausfater P; Dres M; Pourcher V; Luyt CE; Teyssou E; Soulié C; Calvez V; Marcelin AG; Boutolleau D
    Int J Infect Dis; 2021 Jan; 102():10-13. PubMed ID: 33115679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
    Ramasamy R
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper respiratory tract microbiota dynamics following COVID-19 in adults.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Boone HH; Rajagopala SV; Turner JH; Das SR
    Microb Genom; 2023 Feb; 9(2):. PubMed ID: 36820832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of paired upper and lower respiratory tract sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in patients with artificial airways.
    Kitt EM; Davis DH; Kerman C; Sammons JS; Handy LK; Gallagher E; O'Callaghan K; Harris RM; Coffin SE; Bell LM; Chiotos K
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1482-1484. PubMed ID: 33966664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaproteomics for Coinfections in the Upper Respiratory Tract: The Case of COVID-19.
    Bihani S; Gupta A; Mehta S; Rajczewski A; Griffin T; Jagtap P; Srivastava S
    Methods Mol Biol; 2024; 2820():165-185. PubMed ID: 38941023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota.
    Velmurugan G; Vasudevan D
    Biomed J; 2021 Aug; 44(4):504-507. PubMed ID: 34507920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of MERS coronavirus-like viruses in bats: pote1ntial for tracking MERS coronavirus transmission and animal origin.
    Woo PCY; Lau SKP; Chen Y; Wong EYM; Chan KH; Chen H; Zhang L; Xia N; Yuen KY
    Emerg Microbes Infect; 2018 Mar; 7(1):18. PubMed ID: 29511173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy.
    Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F
    Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.